1. Averill MM, Barnhart S, Becker L, Li X, Heinecke JW, LeBoeuf RC, Hamerman JA, Sorg C, Kerkhoff C, Bornfeldt KE. S100A9 Differentially Modifies Phenotypic States of Neutrophils, Macrophages, and Dendritic Cells Implications for Atherosclerosis and Adipose Tissue Inflammation.
   Circulation 123:1216-1226.2011.
2. Baitsch D, Bock HH, Engel T, Telgmann R, Muller-Tidow C, Varga G, Bot M, Herz J, Robenek H, von Eckardstein A, Nofer JR. Apolipoprotein E Induces Antiinflammatory Phenotype in Macrophages.
   Arteriosclerosis Thrombosis and Vascular Biology 31:1160-U1577.2011.
3. Dabritz J, Friedrichs F, Weinhage T, Hampe J, Kucharzik T, Lugering A, Broeckel U, Schreiber S, Spieker T, Stoll M, Foell D. The functional-374T/A polymorphism of the receptor for advanced glycation end products may modulate Crohn's disease.
   American Journal of Physiology-Gastrointestinal and Liver Physiology 300:G823-G832.2011.
4. Ichikawa M, Williams R, Wang L, Vogl T, Srikrishna G. S100A8/A9 Activate Key Genes and Pathways in Colon Tumor Progression.
   Molecular Cancer Research 9:133-148.2011.
5. Lainka E, Bielak M, Hilger V, Basu O, Neudorf U, Wittkowski H, Holzinger D, Roth J, Niehues T, Foell D. Translational research network and patient registry for auto-inflammatory diseases.
   Rheumatology 50:237-242.2011.
6. Nippe N, Varga G, Holzinger D, Loffler B, Medina E, Becker K, Roth J, Ehrchen JM, Sunderkotter C. Subcutaneous Infection with S. aureus in Mice Reveals Association of Resistance with Influx of Neutrophils and Th2 Response.
   Journal of Investigative Dermatology 131:125-132.2011.
7. Rauen T, Benedyk K, Juang YT, Kerkhoff C, Kyttaris VC, Roth J, Tsokos GC, Tenbrock K. A Novel Intronic cAMP Response Element Modulator (CREM) Promoter Is Regulated by Activator Protein-1 (AP-1) and Accounts for Altered Activation-induced CREM Expression in T Cells from Patients with Systemic Lupus Erythematosus.
   Journal of Biological Chemistry 286:32366-32372.2011.
8. Shpacovitch VM, Feld M, Holzinger D, Kido M, Hollenberg MD, Levi-Schaffer F, Vergnolle N, Ludwig S, Roth J, Luger T, Steinhoff M. Role of proteinase-activated receptor-2 in anti-bacterial and immunomodulatory effects of interferon-gamma on human neutrophils and monocytes.
   Immunology 133:329-339.2011.
9. Tuchscherr L, Medina E, Hussain M, Volker W, Heitmann V, Niemann S, Holzinger D, Roth J, Proctor RA, Becker K, Peters G, Loffler B. Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection.
   EMBO molecular medicine 3:129-141.2011.
10. Viemann D, Schmolke M, Lueken A, Boergeling Y, Friesenhagen J, Wittkowski H, Ludwig S, Roth J. H5N1 Virus Activates Signaling Pathways in Human Endothelial Cells Resulting in a Specific Imbalanced Inflammatory Response.
    Journal of Immunology 186:164-173.2011.
11. Voss A, Bode G, Sopalla C, Benedyk M, Varga G, Bohm M, Nacken W, Kerkhoff C. Expression of S100A8/A9 in HaCaT keratinocytes alters the rate of cell proliferation and differentiation.
    Febs Letters 585:440-446.2011.
12. Wittkowski H, Kuemmerle-Deschner JB, Austermann J, Holzinger D, Goldbach-Mansky R, Gramlich K, Lohse P, Jung T, Roth J, Benseler SM, Foell D. MRP8 and MRP14, phagocyte-specific danger signals, are sensitive biomarkers of disease activity in cryopyrin-associated periodic syndromes.
    Annals of the rheumatic diseases 70:2075-2081.2011.
13. Yonekawa K, Neidhart M, Altwegg LA, Wyss CA, Corti R, Vogl T, Grigorian M, Gay S, Luscher TF, Maier W. Myeloid related proteins activate Toll-like receptor 4 in human acute coronary syndromes.
    Atherosclerosis 218:486-492.2011.